Biological
Ended Awarded Last action
- Contract number
- 75N91024F00001
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,258
Award facts
- Contract value 100% obligated
- $24,257.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a BPA call to 10X Genomics, Inc. for biological products with a ceiling value of $24,257.50, awarded October 31, 2023, with ultimate completion by December 31, 2023. Work is performed in Pleasanton, California. The call covers genomic analysis consumables and reagent kits supporting single-cell and spatial transcriptomics research. No set-aside was used.
Quick answers
Who was awarded contract 75N91024F00001?
75N91024F00001 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on October 31, 2023.
How much is contract 75N91024F00001 worth?
The government has obligated $24,258 on 75N91024F00001.
Is contract 75N91024F00001 an order under another contract?
Yes. 75N91024F00001 is a BPA call under 75N98022A00032, a blanket purchase agreement.
Was contract 75N91024F00001 competed?
The extent of competition for 75N91024F00001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award